Antisense oligonucleotides

Intervention1 paper1 finding

Outcomes

1

Lipoprotein

downin humans1

1 study

Antisense oligonucleotides decrease lipoprotein in humans (65% to >95%).
Review
Lipoprotein(a) in the statin era: from risk marker to therapeutic target · Frontiers in pharmacology · 16 Sep 2026

Lipoprotein →

Latest

1

Frontiers in PharmacologyReview2 Oct

Lipoprotein(a) in the statin era: from risk marker to therapeutic target